Evidence map›Paper›PMID 33751731›Full record

ArticleNeuromodulation : journal of the International Neuromodulation Society2021

The Use of Remote Programming for Spinal Cord Stimulation for Patients With Chronic Pain During the COVID-19 Outbreak in China.

Yan Han, Yang Lu, Dengyu Wang, Mingshan Ran, Qidong Ren, Duo Xie, Tipu Z Aziz, Luming Li, James Jin Wang

Registry-linked trialOpen access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Neuromodulation : journal of the International Neuromodulation Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05761392 (Precise Management System), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05761392 narecruitingnot on this mapstarted 2022, after this paper: background citation

Precise Management System (PreMaSy) of Chronic Intractable Pain Based on a Remote and Wireless Spinal Cord Stimulation System

TypeinterventionalSponsorBeijing Tsinghua Chang Gung HospitalRan2022 to 2026Enrolled120ConditionsPain, Chronic, Pain, IntractableArmsPrecise management
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Yan HanSchool of Medicine, Tsinghua University, Beijing, China.ORCID https://orcid.org/0000-0002-2881-1601
Yang LuDepartment of Neurosurgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.ORCID https://orcid.org/0000-0001-9989-6836
Dengyu WangSchool of Medicine, Tsinghua University, Beijing, China.ORCID https://orcid.org/0000-0001-8384-7271
Mingshan RanDepartment of Rehabilitation Medicine, Peking University Shougang Hospital, Beijing, China.
Qidong RenSchool of Medicine, Tsinghua University, Beijing, China.
Duo XieNational Engineering Laboratory for Neuromodulation, School of Aerospace Engineering, Tsinghua University, Beijing, China.
Tipu Z AzizNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
Luming LiNational Engineering Laboratory for Neuromodulation, School of Aerospace Engineering, Tsinghua University, Beijing, China.
James Jin WangDepartment of Neurosurgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.ORCID https://orcid.org/0000-0001-6806-3524
Tsinghua University · CNBeijing Tsinghua Chang Gung Hospital · CNPeking University Shougang Hospital · CNTsinghua–Berkeley Shenzhen Institute · CNUniversity of Oxford · GB

Funding

Beijing Science and Technology Project Z171100001017109National Key Research and Development Program of China 2016YFC0105502National Natural Science Foundation of China 81527901Shenzhen International Cooperative Research Project GJHZ20180930110402104Tsinghua Precision Medicine Foundation
6 · The paper itself

Abstract

objectivesDue to the impact of COVID-19 epidemic, face-to-face follow-up treatments for patients with chronic pain and implanted spinal cord stimulation (SCS) devices are forced to be delayed or stopped. This has led to more follow ups being done remotely. Meanwhile, with the development of 4G/5G networks, smartphones, and novel devices, remote programming has become possible. Here, we investigated the demand and utility of remote follow-ups including remote programming for SCS for patients with chronic pain. MATERIALS AND

methodsA questionnaire including questions on demographic characteristics, pain history, postimplantation life quality, standard follow-up experience, remote follow-up, and remote programming experience was sent to patients diagnosed as chronic intractable pain and treated with SCS during January 2019 to January 2020.

resultsA total of 64 participants completed the questionnaire. About 70% of participants expressed demands for remote follow-ups due to the inconvenience, high costs, and time consumption of traditional follow-up visits. Nearly 97% of participants have attempted remote follow-ups, and about 81% of participants have further tried remote programming. Approximately, 96% of them recognized the benefits.

conclusionsThe remote programming was in high demand among participants. Most of the participants have tried remote follow-ups or even remote programming. The remote programming appeared to be more efficient, economic and were widely recognized among participants.

Indexed as

Implantable NeurostimulatorsAdultChinaChronic PainCOVID-19Disease OutbreaksFemaleFollow-Up StudiesHumansMaleMiddle AgedPain MeasurementRemote Sensing TechnologySpinal Cord StimulationChronic painCOVID-19remote programmingspinal cord stimulationtelemedicine

Identifiers

PMID33751731
PMCPMC8250774
OpenAlexW3138619060

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.